Antinuclear antibodies in healthy population: Positive association with abnormal tissue metabolism, inflammation and immune dysfunction

Burbelo, 2021, Autoantibodies targeting intracellular and extracellular proteins in autoimmunity, Front. Immunol., 12, 10.3389/fimmu.2021.548469 Tešija Kuna, 2021, Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine, Biochem Med (Zagreb), 31, 10.11613/BM.2021.020502 Sur, 2018, Antinuclear antibodies: marker of diagnosis and evolution in autoimmune diseases, Lab. Med., 49, e62, 10.1093/labmed/lmy024 Pisetsky, 2019, ANA as an entry criterion for the classification of SLE, Autoimmun. Rev., 18, 10.1016/j.autrev.2019.102400 Bossuyt, 2020, Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases, Nat. Rev. Rheumatol., 16, 715, 10.1038/s41584-020-00522-w Ling, 2019, Antinuclear antibody tests, Clin. Lab. Med., 39, 513, 10.1016/j.cll.2019.07.001 Sudheer, 2021, Antinuclear antibodies in neurology and their clinical application, QJM, 10.1093/qjmed/hcab304 Solow, 2018, Antinuclear antibodies in the general population: positive association with inflammatory and vascular biomarkers but not traditional cardiovascular risk factors, Clin. Exp. Rheumatol., 36, 1031 Nunes, 2018, Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma - A review, Autoimmun. Rev., 17, 1186, 10.1016/j.autrev.2018.06.009 Long, 2018, Dysregulation of microRNAs in autoimmune diseases: pathogenesis, biomarkers and potential therapeutic targets, Cancer Lett., 428, 90, 10.1016/j.canlet.2018.04.016 Meroni, 2014, Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations, BMC Med., 12, 38, 10.1186/1741-7015-12-38 Li, 2019, Epidemiological survey of antinuclear antibodies in healthy population and analysis of clinical characteristics of positive population, J. Clin. Lab. Anal., 33, e22965, 10.1002/jcla.22965 Chen, 2020, Beijing Da Xue Xue Bao Yi Xue Ban, 52, 886 Zi, 2018, Involvement of cystatin C in immunity and apoptosis, Immunol. Lett., 196, 80, 10.1016/j.imlet.2018.01.006 Xu, 2019, Diagnostic performance of serum cystatin C and complement component 1q in lupus nephritis, Arthritis Res. Ther., 21, 267, 10.1186/s13075-019-2065-x Zanatta, 2019, Inflammation and coronary microvascular dysfunction in autoimmune rheumatic diseases, Int. J. Mol. Sci., 20, 10.3390/ijms20225563 Pandolfi, 2020, Interleukin-6 in Rheumatoid Arthritis, Int. J. Mol. Sci., 21, 10.3390/ijms21155238 Kaur, 2020, A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors, Bioorg. Med. Chem., 28, 10.1016/j.bmc.2020.115327 Tang, 2019, Changes of serum IL-6, IL-17, and complements in systemic lupus erythematosus patients, J. Interferon Cytokine Res.: The Off. J. Int. Soc. Interferon Cytokine Res., 39, 410, 10.1089/jir.2018.0169 A. Ogata, Y. Kato, IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review2019; 29: 258-267. An, 2018, Enhanced neutrophil autophagy and increased concentrations of IL-6, IL-8, IL-10 and MCP-1 in rheumatoid arthritis, Int. Immunopharmacol., 65, 119, 10.1016/j.intimp.2018.09.011 Nilsson, 2019, Increased B-cell activating factor, interleukin-6, and interleukin-8 in induced sputum from primary Sjögren's syndrome patients, Scand. J. Rheumatol., 48, 149, 10.1080/03009742.2018.1473488 Yang, 2020, IL-8 mediates a positive loop connecting increased neutrophil extracellular traps (NETs) and colorectal cancer liver metastasis, J. Cancer, 11, 4384, 10.7150/jca.44215 Lee, 2017, Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review, Autoimmun. Rev., 16, 1160, 10.1016/j.autrev.2017.09.012 Sørensen, 2016, Neutrophil extracellular traps - the dark side of neutrophils, J. Clin. Investig., 126, 1612, 10.1172/JCI84538 Deng, 2019, The emerging epigenetic role of CD8+T cells in autoimmune diseases: a systematic review, Front. Immunol., 10, 856, 10.3389/fimmu.2019.00856 Danikowski, 2017, Regulatory T cells in multiple sclerosis and myasthenia gravis, J. Neuroinflammation, 14, 117, 10.1186/s12974-017-0892-8 Kumar, 2019, Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells, Cell. Immunol., 339, 41, 10.1016/j.cellimm.2018.09.008 Kucuksezer, 2021, The Role of Natural Killer Cells in Autoimmune Diseases, Front. Immunol., 12, 10.3389/fimmu.2021.622306 Chalan, 2016, Altered natural killer cell subsets in seropositive arthralgia and early rheumatoid arthritis are associated with autoantibody status, J Rheumatol, 43, 1008, 10.3899/jrheum.150644 Aggarwal, 2014, Role of cytolytic impairment of natural killer and natural killer T-cell populations in rheumatoid arthritis, Clin. Rheumatol., 33, 1067, 10.1007/s10067-014-2641-z Park, 2009, Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus, Arthritis Rheum., 60, 1753, 10.1002/art.24556 Riccieri, 2000, Down-regulation of natural killer cells and of gamma/delta T cells in systemic lupus erythematosus. does it correlate to autoimmunity and to laboratory indices of disease activity?, Lupus, 9, 333, 10.1191/096120300678828460 Salvi, 2019, Cytokine targeting by miRNAs in autoimmune diseases, Front. Immunol., 10, 15, 10.3389/fimmu.2019.00015 Nakhjavani, 2019, Plasma levels of miR-21, miR-150, miR-423 in patients with lupus nephritis, Iranian J. Kidney Dis., 13, 198 Ma, 2014, Expression, regulation and function of microRNAs in multiple sclerosis, Int. J. Medical Sci., 11, 810, 10.7150/ijms.8647 Wang, 2016, The MicroRNA-21 in autoimmune diseases, Int. J. Mol. Sci., 17 Taheri, 2020, Regulatory and immunomodulatory role of miR-34a in T cell immunity, Life Sci., 262, 10.1016/j.lfs.2020.118209 Xie, 2019, NF-κB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3, J. Autoimmun., 102, 96, 10.1016/j.jaut.2019.04.018 Ghadiri, 2018, Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients, Gene, 659, 109, 10.1016/j.gene.2018.03.035